Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6490
    +0.0001 (+0.02%)
     
  • OIL

    82.55
    -0.81 (-0.97%)
     
  • GOLD

    2,346.40
    +4.30 (+0.18%)
     
  • Bitcoin AUD

    100,069.66
    -2,533.81 (-2.47%)
     
  • CMC Crypto 200

    1,407.63
    -16.47 (-1.16%)
     
  • AUD/EUR

    0.6070
    +0.0013 (+0.22%)
     
  • AUD/NZD

    1.0951
    +0.0021 (+0.19%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,510.63
    +39.16 (+0.22%)
     
  • FTSE

    8,036.45
    -8.36 (-0.10%)
     
  • Dow Jones

    38,357.33
    -146.36 (-0.38%)
     
  • DAX

    18,072.66
    -64.99 (-0.36%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

While McMillan Shakespeare Limited (ASX:MMS) might not be the most widely known stock at the moment, it saw a decent share price growth in the teens level on the ASX over the last few months. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, could the stock still be trading at a relatively cheap price? Let’s examine McMillan Shakespeare’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

Check out our latest analysis for McMillan Shakespeare

Is McMillan Shakespeare Still Cheap?

Good news, investors! McMillan Shakespeare is still a bargain right now. My valuation model shows that the intrinsic value for the stock is A$20.12, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. What’s more interesting is that, McMillan Shakespeare’s share price is theoretically quite stable, which could mean two things: firstly, it may take the share price a while to move to its intrinsic value, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.

What kind of growth will McMillan Shakespeare generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. McMillan Shakespeare's earnings growth are expected to be in the teens in the upcoming years, indicating a solid future ahead. This should lead to robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? Since MMS is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on MMS for a while, now might be the time to enter the stock. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy MMS. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

If you'd like to know more about McMillan Shakespeare as a business, it's important to be aware of any risks it's facing. At Simply Wall St, we found 2 warning signs for McMillan Shakespeare and we think they deserve your attention.

If you are no longer interested in McMillan Shakespeare, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here